Application of modified Charlson comorbidity index for predicting outcomes following adult living donor liver transplantation

Table 3 Postoperative outcomes in the two groups, n (%)

Postoperative outcomes	mCCI ≤ 3 (n = 301)	mCCI > 3 (n = 196)	P value
Prolonged vasopressor support from the end of surgery	129 (42.8)	74 (37.7)	0.25
Early allograft dysfunction	29 (9.6)	24 (12.2)	0.35
Incidence of re-exploration surgery	36 (11.9)	26 (13.2)	0.66
Postoperative renal replacement therapy	11 (3.6)	21 (10.7)	0.002
Incidence of sepsis	53 (17.5)	37 (18.8)	0.71
Incidence of prolonged mechanical ventilation	22 (7.3)	27 (13.7)	0.01
Incidence of lung infections	61 (20.2)	39 (19.8)	0.92
Incidence of cardiac complications	19 (6.3)	22 (11.2)	0.05
Incidence of neurological complications	20 (6.6)	29 (14.7)	0.003
Incidence of wound infection	18 (5.9)	22 (11.2)	0.03
Length of ICU stay (days) (IQR)	6 (5, 8)	6 (5, 10)	0.03
Length of hospital stay (days) (IQR)	16 (13, 20)	17 (14, 22)	0.01
ICU re-admission	29 (9.6)	33 (16.5)	0.01
Morbidity (Clavien-Dindo classification ≥ 3b)	53 (17.6)	57 (29)	0.002
30-day mortality	6 (1.9)	10 (5.1)	0.06
90-day mortality	14 (4.6)	21 (10.7)	0.01

ICU: Intensive care unit; IQR: Interquartile range; mCCI: Modified Charlson comorbidity index.